LPP Antikörper
(2 Referenzen)-
- Target Alle LPP Antikörper anzeigen
- LPP (Lipoma-preferred partner (LPP))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser LPP Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- Verwendungszweck
- LPP Antibody
- Aufreinigung
- Ascitic fluid
- Immunogen
- Purified recombinant fragment of human LPP expressed in E. Coli.
- Klon
- 8B3A11
- Isotyp
- IgG1
-
anti-Lipoma-preferred partner (LPP) (AA 227-391) antibody
LPP Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoma-preferred partner (LPP) antibodyLPP Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Monoclonal unconjugated
anti-Lipoma-preferred partner (LPP) (AA 1-109) antibodyLPP Reaktivität: Human, Ratte, Schwein WB, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoma-preferred partner (LPP) (AA 32-66) antibodyLPP Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB54229 unconjugated
anti-Lipoma-preferred partner (LPP) (Internal Region) antibodyVerified LPP Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Lipoma-preferred partner (LPP) (AA 107-156) antibodyLPP Reaktivität: Human, Maus, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Lipoma-preferred partner (LPP) (N-Term) antibodyLPP Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
ELISA: 1/10000
ICC: 1/200 - 1/1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
: "Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15)." in: Cancer genetics and cytogenetics, Vol. 163, Issue 1, pp. 68-70, (2005) (PubMed).
: "Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules." in: Molecular & cellular proteomics : MCP, Vol. 4, Issue 9, pp. 1240-50, (2005) (PubMed).
-
: "Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15)." in: Cancer genetics and cytogenetics, Vol. 163, Issue 1, pp. 68-70, (2005) (PubMed).
-
- Target
- LPP (Lipoma-preferred partner (LPP))
- Andere Bezeichnung
- LPP (LPP Produkte)
- Hintergrund
-
Description: LIM domain containing preferred translocation partner in lipoma. The Zyxin family of proteins contains five members, Ajuba, LIMD1, LPP,TRIP6 and Zyxin. LPP (LIM-containing lipoma-preferred partner), a LIM domain-containing scaffolding protein contains three LIM domains at its carboxy terminus, which are preceded by a proline-rich pre-LIM region containing a number of protein interaction domains. LPP, an 80 kDa protein, localizes to sites of cell adhesion, such as focal adhesions and cell-cell contacts,and shuttles to the nucleus where it has transcriptional activation capacity.The human LPP gene maps to chromosomal location 3q28, and preferentially translocates to the HMGIC gene in a subclass of human benign mesenchymal tumors known as lipomas.
Aliases: LPP
- Molekulargewicht
- 66kDa
- Gen-ID
- 4026
- HGNC
- 4026
- UniProt
- Q93052
-
